Cham: Springer International Publishing; — Insight into nanoparticle cellular uptake and intracellular targeting. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. A review of glycosylated carriers for drug delivery. Baenziger JU, Maynard Y. Human hepatic lectin. Physiochemical properties and specificity. J Biol Chem. Asialoglycoprotein receptor mediated hepatocyte targeting — strategies and applications.
Drug delivery system targeting advanced hepatocellular carcinoma: current and future. Porous lactose-modified chitosan scaffold for liver tissue engineering: influence of galactose moieties on cell attachment and mechanical stability. Int J Polym Sci. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor ASGPR expression by selected hepatoma cell lines used in antiviral drug development. Curr Drug Deliv.
- Encyclopedia of Tribology.
- Islamic Capital Markets: Volatility, Performance and Stability.
- Soft Computing: Methodologies and Applications (Advances in Soft Computing) (Advances in Intelligent and Soft Computing)?
- The US Commitment to NATO in the Post-Cold War Period?
- Richard Calvocoressi.
- An Introduction to Modeling and Simulation of Particulate Flows (Computational Science and Engineering);
- Modern Business Process Automation: YAWL and its Support Environment.
Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells. A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells. Bioconjug Chem. Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma.
Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. Carbohydr Polym. Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation. Nanomedicine Lond. Galactose-decorated cross-linked biodegradable poly ethylene glycol -b-poly epsilon-caprolactone block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice. Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells. Colloids Surf B Biointerfaces.
Critical Reviews™ in Therapeutic Drug Carrier Systems
Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Asialoglycoprotein receptor targeted gene delivery using galactosylated polyethylenimine-graft-poly ethylene glycol : in vitro and in vivo studies.
Lactose mediated liver-targeting effect observed by ex vivo imaging technology. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma. Sci Rep. Paclitaxel-loaded poly gamma-glutamic acid -poly lactide nanoparticles as a targeted drug delivery system against cultured HepG2 cells. Acta Biomater. Asialoglycoprotein receptor-mediated gene delivery to hepatocytes using galactosylated polymers.
Galactose-based thermosensitive nanogels for targeted drug delivery of iodoazomycin arabinofuranoside IAZA for theranostic management of hypoxic hepatocellular carcinoma. Dependence on fine structural features. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.
Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.
Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer. Galactosylated polymeric carriers for liver targeting of sorafenib. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.
J Mater Sci. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment. Exp Opin Drug Deliv. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.
Glycosaminoglycan-targeted iron oxide nanoparticles for magnetic resonance imaging of liver carcinoma. Mater Sci Eng C. Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer HepG2 cells.
Pectin nanoparticle enhances cytotoxicity of methotrexate against HepG2 cells. Drug Deliv. In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy. Mol Pharm. Evidence for receptor-mediated hepatic uptake of pullulan in rats.
Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab. Kamen BA, Capdevila A. Receptor-mediated folate accumulation is regulated by the cellular folate content. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett.
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein Sorafenib and triptolide as combination therapy for hepatocellular carcinoma. Asian Pacific J Cancer Prev.
- About Face. Military Resisters Turn Against War.
- The Global Climate System: Patterns, Processes, and Teleconnections.
- Centralised Enforcement, Legitimacy and Good Governance in the EU (Routledge Research in EU Law).
- The Treatment of Hodgkin’s Disease;
- Medieval Scotland (Cambridge Medieval Textbooks).
- The Right Ventricle in Adults with Tetralogy of Fallot.
- Hidden Attraction: The History and Mystery of Magnetism (Oxford Paperbacks);
The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model. Clin Exp Pharm Physiol. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Therapeutic efficacy of improved alpha-fetoprotein promoter-mediated tBid delivered by folate-PEIcyclodextrin nanopolymer vector in hepatocellular carcinoma.